Elucid Company
Elucid enables precision medicine for cardiovascular disease by applying A.I to medical image analysis validated against true biology.
Estimated Revenue:
$1M to $10M
Funding Status:
Early Stage Venture
Industry:
Clinical Development
Investors Number:
14.0
Last Funding Date:
2022-06-22
Founded Date:
2013-01-01
Headquarters:
Boston, Massachusetts, United States
Total Funding:
49728339.0
Last Funding Type:
Series B
Employee Number:
51-100